
Shin Lin Chen
Examiner (ID: 17983, Phone: (571)272-0726 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1633, 1632 |
| Total Applications | 1467 |
| Issued Applications | 727 |
| Pending Applications | 150 |
| Abandoned Applications | 592 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10756137
[patent_doc_number] => 20160102289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-14
[patent_title] => 'GENERATION OF KERATINOCYTES FROM PLURIPOTENT STEM CELLS AND MAINTENANCE OF KERATINOCYTE CULTURES'
[patent_app_type] => utility
[patent_app_number] => 14/881747
[patent_app_country] => US
[patent_app_date] => 2015-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 19451
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14881747
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/881747 | Generation of keratinocytes from pluripotent stem cells and maintenance of keratinocyte cultures | Oct 12, 2015 | Issued |
Array
(
[id] => 14790303
[patent_doc_number] => 10398134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Knockout mouse, method for screening substance for suppressing mesial temporal lobe epilepsy, and method for selecting technique for suppressing mesial temporal lobe epilepsy
[patent_app_type] => utility
[patent_app_number] => 15/519030
[patent_app_country] => US
[patent_app_date] => 2015-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 25
[patent_no_of_words] => 6877
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15519030
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/519030 | Knockout mouse, method for screening substance for suppressing mesial temporal lobe epilepsy, and method for selecting technique for suppressing mesial temporal lobe epilepsy | Oct 12, 2015 | Issued |
Array
(
[id] => 12009912
[patent_doc_number] => 09803217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Viral vectors for the treatment of retinal dystrophy'
[patent_app_type] => utility
[patent_app_number] => 14/881960
[patent_app_country] => US
[patent_app_date] => 2015-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 25554
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14881960
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/881960 | Viral vectors for the treatment of retinal dystrophy | Oct 12, 2015 | Issued |
Array
(
[id] => 11942171
[patent_doc_number] => 20170246322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'GUIDED INJECTIONS FOR AAV GENE TRANSFER TO MUSCLE'
[patent_app_type] => utility
[patent_app_number] => 15/517623
[patent_app_country] => US
[patent_app_date] => 2015-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17489
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517623
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517623 | Guided injections for AAV gene transfer to muscle | Oct 8, 2015 | Issued |
Array
(
[id] => 13687581
[patent_doc_number] => 20170354745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN
[patent_app_type] => utility
[patent_app_number] => 15/516872
[patent_app_country] => US
[patent_app_date] => 2015-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/516872 | TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN | Oct 7, 2015 | Abandoned |
Array
(
[id] => 12023879
[patent_doc_number] => 20170313978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'ENDOGENOUS RETROVIRUS TRANSCRIPTION AS A MARKER FOR PRIMATE NAIVE PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/517904
[patent_app_country] => US
[patent_app_date] => 2015-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 26149
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517904
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517904 | ENDOGENOUS RETROVIRUS TRANSCRIPTION AS A MARKER FOR PRIMATE NAIVE PLURIPOTENT STEM CELLS | Oct 6, 2015 | Abandoned |
Array
(
[id] => 11809070
[patent_doc_number] => 09713626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-25
[patent_title] => 'CFTR mRNA compositions and related methods and uses'
[patent_app_type] => utility
[patent_app_number] => 14/876071
[patent_app_country] => US
[patent_app_date] => 2015-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 31390
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14876071
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/876071 | CFTR mRNA compositions and related methods and uses | Oct 5, 2015 | Issued |
Array
(
[id] => 10749754
[patent_doc_number] => 20160095905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'Compositions and Methods for Induced Brown Fat Differentiation'
[patent_app_type] => utility
[patent_app_number] => 14/874697
[patent_app_country] => US
[patent_app_date] => 2015-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 36162
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14874697
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/874697 | Compositions and Methods for Induced Brown Fat Differentiation | Oct 4, 2015 | Abandoned |
Array
(
[id] => 16681984
[patent_doc_number] => 10941452
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Compositions and methods for isolation of circulating tumor cells (CTC)
[patent_app_type] => utility
[patent_app_number] => 15/517143
[patent_app_country] => US
[patent_app_date] => 2015-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 33
[patent_no_of_words] => 12934
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517143
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517143 | Compositions and methods for isolation of circulating tumor cells (CTC) | Oct 4, 2015 | Issued |
Array
(
[id] => 10735979
[patent_doc_number] => 20160082129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'VE-PTP Extracellular Domain Antibodies Delivered by a Gene Therapy Vector'
[patent_app_type] => utility
[patent_app_number] => 14/862948
[patent_app_country] => US
[patent_app_date] => 2015-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22733
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14862948
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/862948 | VE-PTP Extracellular Domain Antibodies Delivered by a Gene Therapy Vector | Sep 22, 2015 | Abandoned |
Array
(
[id] => 10735163
[patent_doc_number] => 20160081313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'Materials and Methods for Producing Animals With Short Hair'
[patent_app_type] => utility
[patent_app_number] => 14/862900
[patent_app_country] => US
[patent_app_date] => 2015-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7653
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14862900
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/862900 | Materials and methods for producing animals with short hair | Sep 22, 2015 | Issued |
Array
(
[id] => 11729595
[patent_doc_number] => 20170191038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'TGFß SIGNALING INDEPENDENT NAÏVE INDUCED PLURIPOTENT STEM CELLS, METHODS OF MAKING AND USE'
[patent_app_type] => utility
[patent_app_number] => 15/326216
[patent_app_country] => US
[patent_app_date] => 2015-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16120
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326216
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326216 | TGFß SIGNALING INDEPENDENT NAÃVE INDUCED PLURIPOTENT STEM CELLS, METHODS OF MAKING AND USE | Sep 17, 2015 | Abandoned |
Array
(
[id] => 11729591
[patent_doc_number] => 20170191034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'A METHOD TO UP-REGULATE CANCER STEM CELL MARKERS FOR THE GENERATION OF ANTIGEN SPECIFIC CYTOTOXIC EFFECTOR T CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/508897
[patent_app_country] => US
[patent_app_date] => 2015-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15680
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508897
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/508897 | A METHOD TO UP-REGULATE CANCER STEM CELL MARKERS FOR THE GENERATION OF ANTIGEN SPECIFIC CYTOTOXIC EFFECTOR T CELLS | Sep 3, 2015 | Abandoned |
Array
(
[id] => 12185764
[patent_doc_number] => 20180044700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION'
[patent_app_type] => utility
[patent_app_number] => 15/502720
[patent_app_country] => US
[patent_app_date] => 2015-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 48238
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502720
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/502720 | Methods and compositions for RNA-directed target DNA modification | Aug 31, 2015 | Issued |
Array
(
[id] => 10738673
[patent_doc_number] => 20160084824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'DRUG DISCOVERY METHODS INVOLVING A PRECLNICAL, IN VITRO ISOLATED GASTROINTESTINAL EPITHELIAL STEM CELL-LIKE PROGENITOR CELL SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/842311
[patent_app_country] => US
[patent_app_date] => 2015-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 25599
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14842311
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/842311 | DRUG DISCOVERY METHODS INVOLVING A PRECLNICAL, IN VITRO ISOLATED GASTROINTESTINAL EPITHELIAL STEM CELL-LIKE PROGENITOR CELL SYSTEM | Aug 31, 2015 | Abandoned |
Array
(
[id] => 12490626
[patent_doc_number] => 09994822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Cardiomyocyte differentiation
[patent_app_type] => utility
[patent_app_number] => 14/834393
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6362
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14834393
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/834393 | Cardiomyocyte differentiation | Aug 23, 2015 | Issued |
Array
(
[id] => 11656149
[patent_doc_number] => 09669133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-06
[patent_title] => 'Extracellular matrix encasement structures and methods'
[patent_app_type] => utility
[patent_app_number] => 14/833404
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 7725
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14833404
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/833404 | Extracellular matrix encasement structures and methods | Aug 23, 2015 | Issued |
Array
(
[id] => 10474918
[patent_doc_number] => 20150359935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'Extracellular Matrix Encasement Structures and Methods'
[patent_app_type] => utility
[patent_app_number] => 14/833327
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7725
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14833327
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/833327 | Extracellular Matrix Encasement Structures and Methods | Aug 23, 2015 | Abandoned |
Array
(
[id] => 11581817
[patent_doc_number] => 09636437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Extracellular matrix encasement structures and methods'
[patent_app_type] => utility
[patent_app_number] => 14/833340
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 7724
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14833340
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/833340 | Extracellular matrix encasement structures and methods | Aug 23, 2015 | Issued |
Array
(
[id] => 12177304
[patent_doc_number] => 20180036240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'CELL MEMBRANE-DERIVED NANOVESICLES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/545398
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9482
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545398
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545398 | Cell membrane-derived nanovesicles and use thereof | Aug 23, 2015 | Issued |